Increasing Use of Oral Appliances is Anticipated to Soar the Growth of Sleep Apnea Devices Market from 2018 to 2025.
Increasing use of oral appliances, availability of wide range of diagnostic and therapeutic devices for sleep apnea are major factors driving the growth of the sleep apnea devices market during the forecast period. Additionally, favorable reimbursement policies for CPAP devices in developed regions such as Europe also fuels the market growth. In Germany, nearly 60% of CPAP treatment costs are reimbursed with the patient paying a small amount out of pocket.
The sleep apnea devices market is segmented on the basis of diagnostics devices, therapeutic devices and end-users. Based on diagnostic devices, global sleep apnea devices market is segmented as polysomnography devices, respiratory polygraphs, actigraphy systems and single-channel screening devices (Oximeters). Among the therapeutic devices, the polysomnography devices segment has largest market share among the diagnostics devices segment. Polysomnography device are most widely used for the diagnosis of sleep apnea and companies are engaged in new product development to achieve growth in the sleep apnea devices market.
Based on therapeutic devices, the sleep apnea devices market is segmented into facial interfaces, Adaptive Servo-Ventilation Instruments (ASV), Positive Airway Pressure (PAP) Devices, oxygen concentrators, airway clearance systems, oral appliances and accessories. Positive Airway Pressure (PAP) Devices has the largest market share among the therapeutic device segment. The portable machine is used for blowing the pressurized room air from into the upper airway which uses. Owing to these factors this market segment has the largest market size. The advantages of the PAP devices are that it is advanced, efficient and easily used.
Based on end user, the global sleep apnea devices market is segmented into hospitals and home. The hospital segment has the largest market share among the end user segment.
Geographically, the sleep apnea devices market is segmented into North America, Europe, Asia Pacific (APC), Middle East and Africa (MEA) and South and Central America (S&CAM).The market for sleep apnea devices is well established in North America region, especially in the US and Canada. The market is the US is governed by the presence of key players manufacturing sleep apnea devices such CPAP devices.
The players operating in the sleep apnea devices market across the globe include ResMed Inc., Koninklijke Philips N.V., Fisher & Paykel, Braebon Medical Corporation, Compumedics Limited, BMC Medical Co., Ltd., Fisher & Paykel Healthcare Limited, SomnoMed Limited, Weinmann Emergency Medical Technology GmbH + Co. KG, Devilbiss Healthcare LLC and others.
